Predictors of comprehensive surgical treatment in patients with ovarian cancer

Cancer

Volumn 109, Issue 10, 2007, Pages 2031-2042

  Goff, Barbara A ^a   Matthews, Barbara J ^a   Larson, Eric H ^a   Andrilla, C Holly A ^a   Wynn, Michelle ^b   Lishner, Denise M ^a   Baldwin, Laura Mae ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cytoreduction; Gynecologic oncologist; Hospital volume; Ovarian cancer; Surgeon volume; Surgery; Teaching hospital

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SURGERY; CAUCASIAN; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; GYNECOLOGY; HEALTH INSURANCE; HISPANIC; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAID; OBSTETRICS; OVARIECTOMY; OVARY CANCER; PREDICTOR VARIABLE; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; QUALITY OF HEALTH CARE; SOCIOECONOMIC FACTORS; SPECIALTIES, SURGICAL; UNITED STATES;

EID: 34248374708     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22604     Document Type: Article

References (46)

1. Ozols RF, Rubin SC, Thomas GM, Robboy SJ. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. 4th ed. New York: Lippincott Williams & Wilkins; 2004.
2. Liede A, Karlan BY, Baldwin RL, Piatt LD, Kuperstein G, Narod SA. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol. 2002;20:1570-1577.
3. NIH Consensus Development Panel on Ovarian Cancer. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. JAMA. 1995;273:491-497.
4. Paley PJ. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol. 2001;184:1021-1030.
5. Nelson HD, Westhoff C, Piepert J, Berg A. Screening for ovarian cancer: brief evidence update. AHRQ Publ. No. 04-0542-B. Rockville, Md: Agency for Healthcare Research and Quality; 2004.
6. Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol. 2002;84:36-42.
7. Eisenkop SM, Spirtos NM, Montag TW, Nalick RH, Wang HJ. The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47:203-209.
8. Junor EJ, Hole DJ, McNulty L, Mason M, Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999;106:1130-1136.
9. Mayer AR, Chambers SK, Graves E, et al. Ovarian cancer staging: does it require a gynecologic oncologist? Gynecol Oncol. 1992;47:223-227.
10. Puis LE, Carrasco R, Morrow MS, Blackhurst D. Stage I ovarian carcinoma: specialty-related differences in survival and management. South Med J. 1997;90:1097-1100.
11. Tingulstad S, Skjeldestad FE, Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol. 2003;102:499-505.
12. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21:3488-3494.
13. Olaitan A, Weeks J, Mocroft A, Smith J, Howe K, Murdoch J. The surgical management of women with ovarian cancer in the south west of England. Br J Cancer. 2001;85:1824-1830.
14. Bristow RE, Zahurak ML, del Carmen MG, et al. Ovarian cancer surgery in Maryland: volume-based access to care. Gynecol Oncol. 2004;93:353-360.
15. Schrag D, Earle C, Xu F, et al. Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection. J Natl Cancer Inst. 2006;98:163-171.
16. Earle CC, Schrag D, Neville BA, et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst. 2006;98:172-180.
17. American College of Obstetricians and Gynecologists. ACOG Committee opinion no 280, December 2002. The role of the generalist obstetrician- gynecologist in the early detection of ovarian cancer. Obstet Gynecol. 2002;100:1413-1416.
18. Agency for Healthcare Research and Quality.HCUP databases. Available at URL: http://www.hcup-us.ahrq.gov/databases.jsp [Accessed May 19, 2006.]
19. American Hospital Association.American Hospital Association Annual Survey of Hospitals database Available at URL: http://www.aha.org/aha/index.jsp [Accessed May 19, 2006.]
20. Morrill R, Cromartie J, Hart LG. Metropolitan, urban, and rural commuting areas: toward a better depiction of the US settlement system. Urban Geogr. 1999;20:727-748.
21. Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) Rural Health Research Center. WWAMI Rural Health Research Center. Available at URL: http://www.fammed.washington.edu/wwamirhrc/ [Accessed January 3, 2006.]
22. National Center for Health Workforce Analysis,Bureau of Health Professions,Health Resources and Services Administration: Area resource file, February 2002 release. Rockville, Md: National Center for Health Workforce Analysis, Bureau of Health Professions, Health Resources and Services Administration, U.S. Department of Health and Human Services; 2002.
23. U.S. Census Bureau.Federal Information Processing Standards (FIPS) codes. Available at URL: http://www.census.gov/geo/www/fips/fips.html [Accessed May 19, 2006.]
24. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care, 1998;36:8-27.
25. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med, 2000;19:1141-1164.
26. Hewitt M, Simone JV. Ensuring Quality Cancer Care. Washington, DC: National Academy Press; 1999.
27. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248-1259.
28. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18:2327-2340.
29. Killeen SD, O'Sullivan MJ, Coffey JC, Kirwan WO, Redmond HP. Provider volume and outcomes for oncological procedures. Br J Surg. 2005;92:389-402.
30. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003;349:2117-2127.
31. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137:511-520.
32. Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA. 2000;283:1159-1166.
33. Nuttall M, van der Meulen J, Phillips N, et al. A systematic review and critique of the literature relating hospital or surgeon volume to health outcomes for 3 urological cancer procedures. J Urol. 2004;172:2145-2152.
34. Joudi FN, Konety BR. The impact of provider volume on outcomes from urological cancer therapy. J Urol. 2005;174:432-438.
35. Skinner KA, Helsper JT, Deapen D, Ye W, Sposto R. Breast cancer: do specialists make a difference? Ann Surg Oncol. 2003;10:606-615.
36. Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am J Public Health. 1998;88:454-457.
37. Elit L, Bondy SJ, Paszat L, Przybysz R, Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol. 2002;87:260-267.
38. Wolfe CD, Tilling K, Raju KS. Management and survival of ovarian cancer patients in south east England. Eur J Cancer. 1997;33:1835-1840.
39. Gandjour A, Bannenberg A, Lauterbach KW. Threshold volumes associated with higher survival in health care: a systematic review. Med Care. 2003;41:1129-1141.
40. Bianco FJ Jr, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol. 2005;173:2099-2103.
41. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300.
42. Kane CJ, Lubeck DP, Knight SJ, et al. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology. 2003;62:1035-1039.
43. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20:1192-1202.
44. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
45. Ball JK, Elixhauser A. Treatment differences between blacks and whites with colorectal cancer. Med Care. 1996;34:970-984.
46. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997;15:3408-3415.